ARCHIVES

Adding Aresenic To Therapy Improves APL Survival

This article is from The Cancer Letter archive.

Vol. 30 No. 7 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

McGivney Out at NCCN as Board Cites Management Style, Strategic Direction

January 13, 2012

UNM Cancer Center Appoints Four Leaders

May 24, 2013

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

HHS Carcinogen Guidelines For Labs Could Apply To Other

May 30, 1980

Cancer Nurses Urged To Take ‘Proactive Stance’ against Budget Cutting

October 16, 1987

Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions

September 27, 1996